Merck & Co. Files 2024 Annual Report
Ticker: MRK · Form: 10-K · Filed: Feb 25, 2025 · CIK: 310158
Sentiment: neutral
Topics: annual-report, pharmaceuticals, financials
TL;DR
Merck filed its 2024 10-K, check financials and strategy.
AI Summary
Merck & Co., Inc. filed its 10-K for the fiscal year ended December 31, 2024, reporting on its operations in the pharmaceutical preparations industry. The company, headquartered in Kenilworth, NJ, is a significant player in the life sciences sector. This filing provides a comprehensive overview of its financial performance and business activities for the past fiscal year.
Why It Matters
This 10-K filing provides investors and the public with a detailed look at Merck's financial health, strategic direction, and potential risks for the fiscal year 2024.
Risk Assessment
Risk Level: medium — As a large pharmaceutical company, Merck faces inherent risks related to drug development, regulatory approvals, market competition, and patent expirations.
Key Players & Entities
- Merck & Co., Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-02-25 (date) — Filing date
- Kenilworth, NJ (location) — Company headquarters
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What was Merck & Co., Inc.'s fiscal year end?
Merck & Co., Inc.'s fiscal year end was December 31, 2024.
When was this 10-K filing submitted to the SEC?
This 10-K filing was submitted on February 25, 2025.
What is Merck & Co., Inc.'s Standard Industrial Classification code?
Merck & Co., Inc.'s Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.
Where is Merck & Co., Inc. headquartered?
Merck & Co., Inc. is headquartered in Kenilworth, NJ.
What is the SEC file number for Merck & Co., Inc.'s 10-K filing?
The SEC file number for Merck & Co., Inc.'s 10-K filing is 001-06571.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on February 25, 2025 regarding Merck & Co., Inc. (MRK).